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Abstract
Cancer is now the leading cause of death in Japan. A rapid increase in cancer mortality is expected as Japan is
facing a super-aged society. Many causes of cancer are known to be closely linked to life style factors, such as
smoking, drinking, and diet. The oral environment is known to be involved in the pathogenesis and development
of various diseases such as bronchitis, pneumonia, diabetes, heart disease, and dementia. Because the oral cavity
acts as the bodily entrance for air and food, it is constantly exposed to foreign substances, including bacteria and
viruses. A large number of bacteria are endemic to the oral cavity, and indigenous oral flora act to prevent the
settlement of foreign bacteria. The oral environment is influenced by local factors, including dental plaque, tartar,
teeth alignment, occlusion, an incompatible prosthesis, and bad lifestyle habits, and systemic factors, including
smoking, consumption of alcohol, irregular lifestyle and eating habits, obesity, stress, hormones, and heredity. It has
recently been revealed that the oral environment is associated with cancer. In particular, commensal bacteria in the
oral cavity are involved in the development of cancer. Moreover, Candida, human papilloma virus and Epstein-Barr
virus as well as commensal bacteria have been reported to be associated with the pathogenesis of cancer. In this
review, we introduce recent findings of the correlation between the oral environment and cancer.
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Background
During 2012, approximately 14.1 million new cases of
human cancer were reported globally [1]. In Japan, the
estimated number of cancer deaths during 2014 was
approximately 367,000 [2]. Regarding the age-specific
causes of death, during 2013, cancer was the leading
cause of death among 40–89 years in Japan [2]. Tobacco
use accounts for approximately 22 % of cancer deaths
[3], followed by obesity, a poor diet, lack of physical
activity, and consumption of alcohol, which collectively
account for 10 % of cancer deaths [3, 4]. Other factors
include infections, exposure to ionizing radiation, and
environmental pollutants [5]. Thus, various causes of
cancer are known to be closely involved in lifestyle
choices, such as smoking, drinking, and diet.
The human body is inhabited by over 100 trillion
microbial cells living in symbiosis with the host. Many
bacteria are endemic to the oral cavity. More than 700
bacterial species inhabit the oral cavity, including at least
11 bacterial phyla and 70 genera. Individuals that prac-
tice oral hygiene have 1,000–100,000 bacteria living on
each tooth surface, whereas those who do not regularly
practice dental hygiene can have between 100 million
and 1 billion bacteria on each tooth surface [6]. Al-
though some bacteria of the oral cavity are harmful and
can cause serious disease, many of the oral bacteria are
in fact beneficial in preventing diseases. Thus, the oral
cavity is inhabited by complex multispecies bacterial
communities that usually exist in a balanced immunoin-
flammatory state with the host [7]. It is now established
that many chronic inflammatory conditions are caused
by an imbalance between host-microbiota interactions,
resulting in a dysbiotic community, deregulated immune
responses, and eventually disease outcomes. Oral com-
mensal bacteria play a critical role in the development of
oral diseases, including periodontal disease and tooth
loss, and maintenance of a normal oral physiological
environment [8, 9]. In addition, oral commensal bacteria
are involved in the pathogenesis of cancer [10]. Thus,
the oral environment including oral commensal bacteria
is known to be involved in the pathogenesis and devel-
opment of various diseases, such as bronchitis and
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pneumonia, diabetes, heart disease, and dementia. The
oral environment is influenced by local factors, including
dental plaque, tartar, teeth alignment, occlusion, an
incompatible prosthesis, and bad lifestyle habits, and
systemic factors, including smoking, consumption of al-
cohol, an irregular lifestyle, eating habits, obesity, stress,
hormones, and heredity factors (Fig. 1). Majority of the
causes of cancer are thought to be related to tobacco use
and heavy alcohol consumption. In the oral environ-
ment, poor oral hygiene and viral and Candida infections
can be risk factors for cancer.
Oral bacteria and cancer
The link between oral infections and adverse systemic
conditions has attracted a great deal of attention in the
dental and medical fields. A major consequence of the
systemic spread of oral commensals and pathogens to
distant body sites has been the disruption of immune
surveillance and homeostasis, resulting in the promotion
or acceleration of pathogenic processes. Oral bacteria
are involved in systemic infections and inflammation
such as cardiovascular disease, adverse pregnancy out-
comes, rheumatoid arthritis, aspiration pneumonia, in-
flammatory bowel disease, organ inflammations, and
cancer (Fig. 1). Cumulative studies have revealed that
oral bacteria are involved in the initiation or progression
of certain cancers. Chronic or dysregulated inflammation
contributes to tumor development, partly through the
modulation of the tumor microenvironment [11]. Epi-
demiological studies have shown that the risk of cancer
is increased in people with periodontal disease or tooth
loss caused by oral bacteria [12]. Oral diseases, including
periodontitis, have been related to the risk of oral and
gastrointestinal cancers, such as oral, esophageal, gastric
and pancreatic cancers [13, 14]. Although the underlying
mechanism for the associations between oral health
status and cancers are not completely understood, it
has been reported that Fusobacterium nucleatum and
Porphyromonas gingivalis are involved in cancer
development.
F. nucleatum, an anaerobic Gram-negative oral
commensal, is associated with periodontitis, adverse
pregnancy outcomes, cardiovascular disease, rheumatoid
arthritis, inflammatory bowel disease, and colon cancer
[15]. This bacterial species is a key component of peri-
odontal plaque because of its abundance and ability to
coaggregate with other species in the oral cavity [16, 17].
Elevated F. nucleatum levels were significantly detected
in people with colon cancers compared with that in
people with normal colon tissue [18, 19]. The bacteria
genera of Fusobacterium, Porphyromonas, Peptostrepto-
coccus, and Mogibacterium were found to be enriched in
the mucosa-adherent microbiota of people with colon
cancer [20]. Moreover, the overabundance of Fusobacter-
ium in people with colon cancer was positively associ-
ated with lymph node metastasis [18]. In cases of colon
cancer, a positive correlation between mRNA levels for
several local cytokines and Fusobacterium species has
been observed [21]. Although the mechanism by which
F. nucleatum might contribute to the pathogenesis of
such a diverse clinical spectrum is unknown, recent
studies have demonstrated the mechanisms of F. nuclea-
tum in the involvement of colon cancer as follows: i) F.
nucleatum induces oncogenic and inflammatory re-
sponses to stimulate growth of colon cancer cells
through FadA adhesin via binding with E-cadherin and
ensuing activation of ß-catenin signaling [22], ii) F.
nucleatum generate a proinflammatory microenviron-
ment for the progression of colon cancer through the
recruitment of tumor-infiltrating immune cells [23], and
Fig. 1 Influence of Oral Environment on Systemic Disease. The oral environment is influenced by local factors, including dental plaque, tartar,
teeth alignment, occlusion, an incompatible prosthesis, and bad lifestyle habits, and systemic factors, including smoking, consumption of alcohol,
an irregular lifestyle, eating habits, obesity, stress, hormones, and heredity factors. The oral environment is involved in systematic diseases, such as
diabetes, preterm birth and low birth weight, cancer, respiratory disease, cardiovascular disease and cerebrovascular disease
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iii) F. nucleatum interferes with the host immunity by
engaging its bacterial protein Fap2 with the inhibitory
immunoreceptor TIGIT on NK and T cells [24] (Fig. 2).
Accumulated evidence has shown strong correla-
tions between a number of chronic periodontal
bacteria containing Prevotella, Porphyromonas and
Streptococcus spp. and orodigestive cancer, including
oral squamous cell carcinoma and pancreatic cancer
[25–31]. P. gingivalis have an abundance of virulence
factors and can be present in periodontal pockets. P.
gingivalis has a major disruptive effect on local im-
mune responses in the periodontal area [7]. Moreover,
it can survive within the oral epithelial tissues and
can evade the host immune response [32–37]. In vitro
studies have demonstrated that i) P. gingivalis strains
can induce the expression of the B7-H1 and B7-DC
receptors in oral cancer cells, which might facilitate
immune evasion by oral cancers [38] and ii) P. gingi-
valis activates the ERK1/2-Ets1, p38/HSP27, and
PAR2/NF-kB pathways to induce proMMP9 expres-
sion, after which the proenzyme is activated by gingi-
pains to promote cellular invasion of oral cancer cells
[39]. In primary cultures of gingival epithelial cells, P.
gingivalis is strongly antiapoptotic and can suppress
chemically induced apoptosis via activation of the
Jak1/Akt/Stat3 signaling pathway [40, 41], suggesting
that the antiapoptotic effect of P. gingivalis may be
involved in carcinogenesis. Thus, both P. gingivalis
and F. nucleatum are involved in cancer progression
via activation of cell signaling and/or facilitating
immune evasion. However, the possible link between
oral bacterium and cancer development remains to be
investigated in molecular detail.
Viral and Candida infection and cancer
Tobacco and alcohol are considered as major risk factors
for cancer; however, viral and candidal infection is
increasingly being identified to play significant roles in
cancer development [42]. Human papillomaviruses
(HPVs) are small, double-stranded DNA viruses that
induce hyperproliferative lesions in epithelial tissues
[43, 44]. More than 100 types of HPV have been identi-
fied. Among them, high-risk HPV types, including HPV
type 16 (HPV-16), HPV-18, HPV-31, HPV-33, and
HPV-42, induce lesions in the genital tract that can pro-
gress to malignancy [44–46]. HPV is the most common
sexually transmitted viral infection and is well-known as
the causative agent of cervical cancer. HPV infection
has also been detected in the oral cavity. A large num-
ber of studies have demonstrated a 2–3-fold increase in
the prevalence of HPV-driven oropharyngeal squamous
cell carcinoma over the last three decades, particularly
in North America and northern Europe [47–49]. More-
over, a recent review found that many studies have iden-
tified a high proportion of oral cancer with detectable
HPV DNA [50]. Although the underlying reasons
remain poorly understood, changes in sexual behavior,
decreased rates of tonsillectomy performed in the
pediatric population since the 70s, and progress in the
diagnostic work-up and HPV testing assays have been
proposed as the reasons [51–55]. Considering current
trends, it is estimated that high-risk HPVs, such as
HPV16 and HPV18, cause premalignant lesions [54, 55].
In the high-risk HPV types, E6 and E7 have been shown
to function as oncoproteins [56, 57]. E6 and E7 onco-
proteins are the key drivers of tumorigenesis by inacti-
vating the tumor suppressors pRb and p53 [58].
Fig. 2 Involvement of F. nucleatum in colon cancer development. Figure shows the mechanisms of F. nucleatum in the involvement of colon
cancer. F. nucleatum promotes E-cadherin/ß-catenin signaling via FadA adhesin and protects from immune attack by engaging its bacterial
protein Fap2 with the inhibitory immunoreceptor TIGIT on NK and T cells. Moreover, F. nucleatum generate a proinflammatory microenvironment
through the recruitment of tumor-infiltrating immune cells
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Epstein–Barr virus (EBV) causes infectious mono-
nucleosis and oral hairy leukoplakia, and is associated
with various types of lymphoid and epithelial malignan-
cies. During 1964, Epstein et al. determined the causa-
tive agent of Burkitt’s lymphoma to be a previously
unknown member of the herpes family of viruses, later
termed as EBV [59]. Burkitt lymphoma can be classified
into three forms, which differ in geographic distribution
and EBV association: endemic, sporadic, and HIV associ-
ated Burkitt lymphoma. Among them, endemic Burkitt
lymphoma is associated with EBV in over 95 % cases
[60]. Endemic Burkitt lymphoma is predominant in the
equatorial belt of Africa and other parts of the world
where malaria is hyperendemic [60–63]. On the other
hand, although controversial, lymphoepithelial carcin-
oma and nasopharyngeal carcinoma may also be associ-
ated with EBV [64–68]. The association between
lymphoepithelial carcinoma and EBV appears to differ
according to geographic areas, race, and affected organs.
In general, the association of lymphoepithelial carcinoma
with EBV is strong in the head and neck region, whereas
it is relatively weak at other sites. Moreover, the associ-
ation is strong in East Asia and relatively weak in
western countries. To a great extent, EBV-mediated dis-
ruption of cell growth checkpoints relies on direct
modulation of cytokine receptor signaling mechanisms
and alterations in the expression levels of various cyto-
kines [69]. Moreover, EBV is associated with aggressive
types of oral tumors, particularly in immunosuppressed
patients [70]. Thus, EBV infection of the oral cavity is
also associated with certain types of cancer. However,
the pathogenesis of these tumors remains unclear.
Oropharyngeal candidiasis is an opportunistic infec-
tion primarily caused by Candida albicans, a ubiquitous
fungal organism that is part of the normal microflora of
the gastrointestinal and reproductive tracts. Candida
species can be isolated as a commensal organism from
the oral cavity in up to 80 % healthy individuals [71].
Depending on the host defense mechanisms or oral
microenvironment, Candida species can transform from
a harmless commensal species to pathogenic organisms
causing oral mucosal infection [72, 73]. Candida-associ-
ated denture stomatitis affects more than 25 % denture
wearers [74], and up to 90 % HIV+ patients have had at
least one episode of oropharyngeal candidiasis [75].
When dealing with a hyperplastic epithelial lesion of the
oral mucosa in which presence of C. albicans is demon-
strated, it is referred to by many as Candida-associated
leukoplakia or others prefer the term “hyperplastic
candidiasis.” Chronic hyperplastic candidiasis showed a
higher rate of malignant transformation on follow-up
[76]. Animal studies have shown that Candida can cause
epithelial hyperplasia and cellular atypia [77]. Strains of
Candida can produce carcinogenic nitrosamine, N-
nitrosobenzylmethylamine [78]. Thus certain strains of
Candida play a key role in oncogene formation and
initiation of cancer development [77–79]. However, the
possible role of Candida in malignant transformation
remains still unclear.
Conclusion
Many of the causes of cancer are known to be closely
linked to lifestyle factors, such as smoking, drinking, and
diet. The oral environment is associated with the cause
of various diseases, including cancer. The oral environ-
ment is influenced by various factors, including local
and systemic factors. In the current review, in particular,
we introduced the involvement of oral bacteria, fun-
guses, and viruses in the development of cancer. During
recent years, the role of oral care for the management of
general health has been found to be important within
the fields of medical and nursing care. Therefore, oral
care for the management of the oral environment can be
important for prevention of cancer.
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